Jason Ho is an experienced professional in corporate development and investment, currently serving as the Head of Corporate Development at PHASE Scientific International Limited since September 2022. Previously, Jason held the position of Vice President of Healthcare Investment at VMS Group from June 2016 to August 2022, contributing to a financial group with over USD 3.8 billion in assets under management. Jason's investment expertise is further demonstrated through roles as Lead Investor at Chime Biologics and New Horizon Health Limited, and as an investor at Kindstar Global, Chemclin Diagnostics, and Careray Digital Medical Technology Co., Ltd. Early career experience includes serving as an Associate at Baker & McKenzie, specializing in cross-border M&A and corporate governance. Jason holds a Master of Medical Sciences, a Postgraduate Certificate in Laws, and dual Bachelor's degrees in Laws and Business Administration, all from The University of Hong Kong.
This person is not in any teams
PHASE Scientific International Limited
Phase Scientific is a biotech firm that creates diagnostic and data tools to help healthcare providers and patients. They provide tools for cancer, oncology, nipt, molecular diagnostics, NGS, dd PCR, point of care, liquid-phase extraction, sample preparation, purification, enrichment, size selection, cell-free DNA, cfDNA extraction, RNA extraction,viral RNA extraction, DNA methylation, library preparation, and liquid biopsy.